---
title: "About"
description: "Built by scientists, for scientists. The team behind Amass and the case for unifying life-science research under one engine."
url: https://amass.tech/about
---

# About

About Amass

# Built for scientific work. Designed for evidence.

We built Amass because scientific work increasingly depends on fragmented evidence spread across too many systems, tools and teams and time. Search alone is not enough. Teams need infrastructure that helps them retrieve, verify, structure and reuse knowledge without losing the source trail.

Mission

## Make scientific intelligence reliable, traceable and reusable.

Life science decisions are only as good as the evidence behind them. But that evidence is often scattered across papers, patents, trials, regulatory sources, internal documents and team knowledge.

Amass turns fragmented scientific knowledge into a shared intelligence layer. Every answer, workflow and output can be traced back to the underlying source — so researchers, investors, developers and strategy teams can work from the same evidence base.

Human judgment stays in control. Amass provides the evidence infrastructure underneath.

500M+documents indexed

8specialized data layers

2022Founded

CopenhagenDenmark

How we got here

## From biomedical search to scientific intelligence infrastructure

Amass started from a simple problem: life science teams make important decisions from evidence that is scattered across data sources and availability.

Our early work focused on biomedical retrieval, helping teams search scientific literature with more precision, coverage and traceability. Since then, Amass has expanded into a broader scientific intelligence layer: connecting multiple evidence sources, structuring them into workflows, and making every answer traceable back to the underlying source.

Today, Amass supports evidence-heavy work across research, due diligence, competitive intelligence, portfolio monitoring, target evaluation and scientific strategy.

Amass \*Core

### The Amass \*Core infrastructure

-   BiomedCoreBiomedical literature and citations.
-   ScholarCoreScholarly literature across every discipline.
-   PatentCorePatents, claims, families and ownership.
-   RegulatoryCoreFDA, EMA and regulatory documents.
-   DrugCoreDrugs, molecules and modalities.
-   TrialCoreClinical trials, sponsors and endpoints.
-   GeneCoreHuman genes, targets, and druggability.
-   WebCoreReal-time company, market and conference news.

App, API and MCP

One scientific intelligence layer, available wherever teams work.

How we work

## What makes Amass different

### Evidence-first, not answer-first

Amass starts by retrieving the relevant source material, then structures, synthesizes and reasons.

### Built for life science complexity

The platform works across data in life sciences, publications, patents, clinical trials, regulatory sources, web data and internal documents.

### Traceable by default

Every answer, workflow and output links back to the underlying source, so teams can review, verify and reuse the evidence.

Founders

## Science depth. Commercial execution.

### Alexander Junge

Co-Founder & CTO

Bioinformatics PhD and former Novo Nordisk data scientist. Built the Amass data engine from the ground up, combining biomedical retrieval, scientific data infrastructure and applied AI for life science workflows.

PhD BioinformaticsNovo Nordisk18,000+ citationsAI/MLScientific retrieval

### Henrik Jensen

Co-Founder & CEO

Commercial and organizational lead with experience scaling digital products, fundraising, partnerships and go-to-market. Previously built and exited product-led companies and advised life science and technology organizations.

CEO / GTMIPO experienceExit experienceVC / fundraisingLife science strategy

Team

## Built by people who have worked inside the problem

### Jörn Petersen

AI & Data Engineer

Founding engineer behind Novo Nordisk's BraiNN biomedical knowledge graph. Builds the data pipelines, retrieval systems and scientific infrastructure behind Amass.

Novo Nordisk BraiNNBiomedical knowledge graphsIBM Watson Health

### René Bischoff

Platform and Infra Engineer

Full-stack and infrastructure engineer. First engineer at Pleo and built their infrastructure from the ground up. Builds the platform layer that makes Amass reliable in production.

Platform EngineerInfrastructureAPI and MCP

### Lluís Colomer Coll

AI Engineer

Leads development of Amass agents and applied AI workflows. Focused on model orchestration, research workflows and production-grade scientific agents.

MSc Human-Centered AIAmass Agents lead

### Emil Cronval

GTM Engineer

Builds the bridge between product, operations and go-to-market. Owns automation, customer workflows and internal systems that help Amass move faster.

AI GTMOperationsAutomationSales workflows

### Heidi Noddeland

Business Development

Life science commercial strategy and partnerships. PhD in pharmaceutical sciences with experience in pharma, biotech and innovation consulting.

PhD Pharmaceutical SciencesLEO PharmaBioInnovation / consultingPartnerships

### Niels Andersen

Product & UX Strategy

Shapes product direction and user-facing workflows. 20 years of product strategy and design across enterprise and startup environments.

Product strategyUXEnterprise softwareLife science workflows

### Kris Modig

Scientific Solutions, Enterprise Growth Lead

Helps life science organizations put the Amass scientific data layer to work in their research and decision-making. Five years bridging science and data in antibody and biologics discovery, most recently at Benchling and before that at PipeBio.

BenchlingPipeBio

We're hiring

### ML / Research Engineer

Work on retrieval, grounding, and scientific reasoning across 500M+ documents. Strong ML fundamentals, comfort shipping to production.

Copenhagen · on-siteFull-time

[See the role→](https://amass.tech/careers)

We're hiring

### Platform Engineer

Scale the infrastructure that serves the Amass cores and API to research teams worldwide. Backend, data, and distributed systems chops.

Copenhagen · on-siteFull-time

[See the role→](https://amass.tech/careers)

Open application

### Don't see your role?

If you're strong in life science, infrastructure, or AI — and you'd like to build the research foundation we wish existed — we'd like to talk.

All disciplines

[Get in touch→](mailto:hello@amass.tech)

Board

## Our strategic backbone

A board of seasoned leaders whose global perspectives and proven track records provide the governance and insight that drive our mission forward.

### Dr. Christian Thirion

Chairman

Founder and MD of SIRION Biotech GmbH, a Munich-based biotech firm recognized as a leader in viral vector development and cell modeling for preclinical research (sold to Revvity). Also serves as board member at Lysomab and Hervolution.

### Tommy Ahlers

Board member

Partner at Giant Ventures. Former Danish Minister for Science and Higher Education and MP. Founded/built ZYB and Podio (exit to Vodafone and Citrix) and chair of Peakon and Lix.

### Bodil Sidén

Board member

General Partner at KOST Capital, an early-stage VC investing in food and bioeconomy-driven innovation. Former Partner at blq invest, backing early-stage ventures like Ingrid, Bower and Hydda.

Backed by

## World-class investors

Seasoned bio, tech, and pharma investors backing our mission to unify life science research intelligence.

## We are building the scientific intelligence infrastructure for life science.

If you want to build the evidence layer behind better scientific decisions, we would like to talk.

[See open roles →](https://amass.tech/careers)[Get in touch →](mailto:hello@amass.tech)
